EGRX earnings call for the period ending March 31, 2019.
News & Analysis: Eagle Pharmaceuticals
EGRX earnings call for the period ending December 31, 2018.
EGRX earnings call for the period ending December 31, 2017.
Great stocks for smart investors can be found in different corners of the market.
Acadia Pharmaceuticals, Regeneron Pharmaceuticals, and Eagle Pharmaceuticals all look like solid choices for the year ahead.
A newly minted J-code from CMS provides additional clarity into the company's future sales from Bendeka.
A solid second-quarter earnings report buoyed by good news from the FDA sent shares soaring.
A positive decision on a key patent has investors bullish about the company's future.
The FDA declines to approve Kangio, sending Eagle's shares spiraling downward today.
These big biotech winners more than tripled in value this year.